Successful BNC101 IND Submission Paves Way For Development Of Promising Cancer Stem Cell Drug Candidate

ADELAIDE, Australia, Aug. 31, 2015 /PRNewswire/ — Bionomics Limited (ASX:BNO, ADR:BMICY), a biopharmaceutical company focused on the discovery and development of innovative therapeutics for the treatment of diseases of the central nervous system (CNS) and …

[Read the full article here]

Comments are closed.